Press Release

Peptide Therapeutics Market worth 9.67% CAGR by 2026

May, 2021

" COVID-19 Impact on Peptide Therapeutics market, size, share, growth, industry analysis, and forecast 2020-2026 "

Peptides are the mixture of two or more amino acid monomers connected by amide bonds. Researchers have illustrated that peptides are different from proteins based on size. Peptides as a benchmark are determined as molecules with less than 50 amino acids. Peptides function by binding to particular cell surface receptors and impersonates such as receptor ligands and assisting in treating diseases by acting on the cell membrane.

Technology-driven advancements have been favorable in curtailing the overall costs incurred in the manufacturing of peptide therapeutics. This has influenced manufacturers to unleash new manufacturing peptide therapeutics and address elongated and complicated peptides. A complete inclination towards hybrid technologies to minimize the burden on resources is expected to compel the peptide therapeutics market growth in the coming years.

Request for sample copy of the report @

In the present scenario peptide therapeutics market is a booming one, as there has been a reduction in non-peptide chemical drugs present in the market. An increase in the patent cliff has projected the growth of the peptides generics market. The contract manufacturing companies that render end-to-end service for the biotech & pharmaceutical companies are increasing due to the changing focus of pharma companies exploring greater opportunities in the peptide therapeutics market. In the beginning, the peptides had applications only in diagnostics and hormonal therapy; somehow, with the advanced technology, peptides are now vastly being used for therapeutic applications of cancer and chronic metabolic diseases.

The Peptide Therapeutics Market research report titled “Peptide Therapeutics Market by Application, Drug Type, Type of Manufacturing, Synthesis Technology and Geography – Global Forecast up to 2026.

The top companies operating in the market are Teva Pharmaceuticals Industries Ltd., Novo Nordisk A/S, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, and GlaxoSmithKline plc (GSK).

Access full report summary @

North America has a significant role in the peptide therapeutics market growth. Well-developed healthcare infrastructure, high-cost peptide therapeutics, beneficial reimbursement policies, and structure accelerate the peptide therapeutics market growth in the region.

The report consists of 118 Tables and 88 charts depicting the in-depth market study and the impact analysis of COVID-19. View detailed TOC here.

Peptide Therapeutics Market by Application

  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Anti-infection
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Others

Peptide Therapeutics Market by Drug Type

  • Generic
  • Innovative

Peptide Therapeutics Market by Type of Manufacturing

  • In-house
  • Outsourced

Peptide Therapeutics Market by Synthesis Technology

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

Peptide Therapeutics Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Mr. Karthick Subramani

Infoholic Research LLP

Marketing & Communication